Ocular findings in human immunodeficiency virus patients in Washington, DC
International Ophthalmology, 04/04/2012
Kaleem MA et al. – In this study, the authors find that the overall prevalence of ocular disease has decreased since the introduction of highly active antiretroviral therapy (HAART). However, human immunodeficiency virus (HIV) patients continue to be predisposed to developing ophthalmic disease at higher rates than the general population. Visual dysfunction remains an important source of morbidity in HIV patients, particularly in those with acquired immune deficiency syndrome. Measures for improvement include increased communication between infectious disease specialists and ophthalmologists to ensure adherence to HAART and routine eye examinations.
